Search

everythinglearnresearchcommunity

for

Search:↓

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Topical tacrolimus reduces certain growth factors in hair follicles.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Nanostructured lipid carriers can improve alopecia treatment by enhancing drug delivery and promoting hair growth.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Trichoscopy is easier and quicker than folliscopy for diagnosing telogen effluvium.

Estrogen helps promote hair growth in women with androgenetic alopecia.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Two growth factors, PDGF and FGF2, can potentially be used together to grow enough cells for a hair loss treatment, but their exact function on human cells needs further confirmation.

New treatments for hair loss show promise, especially with antiandrogens, minoxidil, and autoimmune therapies.

Tiny glowing gold particles can stop hair growth by blocking a specific cell signal.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Neurotrophins are important for hair growth and response to stress.

Certain growth factors regulate hair growth cycles, male hormones affect hair cycles, and drugs like Minoxidil and Finasteride can stimulate hair growth and inhibit male pattern baldness respectively.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.